Breast cancer screening discussions for women in their forties

Breast Disease

Volumn 13, Issue , 2001, Pages 21-31

  Kinsinger, L S ^a   Harris, R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; DECISION MAKING; FEMALE; HUMAN; MEDICAL INFORMATION; PATIENT CARE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STANDARD;

EID: 0035203120     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/BD-2001-13104     Document Type: Article

References (53)

1. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: Comparison of relative and absolute benefit
2. Benefit of screening mammography in women ages 40-49: A new meta-analysis of randomized controlled trials
3. Clinical strategies for breast cancer screening: Weighing and using the evidence
4. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age
5. Pain during mammography: Characteristics and relationship to demographic and medical variables
6. Complications associated with needle localization biopsy of the breast
7. Localization and needle aspiration of breast lesions: Complications in 370 cases
8. Safety, accuracy, and diagnostic yield of needle localization biopsy of the breast performed using local anesthesia
9. Quality of life following a false positive mammogram
10. Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England
11. Heuvel A. Distressed or relieved? Psychological side effects of breast cancer screening in the Netherlands
12. Psychiatric morbidity associated with screening for breast cancer
13. Psychological and behavioral implications of abnormal mammograms
14. Ten-year risk of false positive screening mammograms and clinical breast examinations
15. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: A dilemma
16. Incidence of and treatment for ductal carcinoma in situ of the breast
17. Treatment selection in ductal carcinoma in situ
18. Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997) - Behavioral Risk Factor Surveillance System
19. Informed decision making in outpatient practice: Time to get back to basics
20. Decision aids for patients considering options affecting cancer outcomes: Evidence of efficacy and policy implications
21. Clinical factors that influence patients' desire for participation in decisions about illness
22. Do patients wish to be involved in decision making in the consultation? A cross sectional survey with video vignettes
23. Interest in decision-making about breast cancer screening in younger women
24. Men want to participate in the PSA decision
25. Patients' participation in medical care: Effects on blood sugar control and quality of life in diabetes
26. Supporting and resourcing treatment decision-making: Some policy considerations
27. Introducing patient values into the decision making process for breast cancer screening
28. Cancer screening and informed patient discussions. Truth and consequences
29. Gaining informed consent for screening is difficult-but many misconceptions need to be undone
30. Putting the "informed" in informed consent about mammography
31. Decision aids for patients facing health treatment or screening decisions: Systematic review
32. Practical issues in assisting shared decision-making
33. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age
34. Worry about breast cancer in younger women: A major problem
35. Decision aids for people facing health treatment or screening decisions
36. Pilot study of an information aid for women with a family history of breast cancer
37. Validation of a decisional conflict scale
38. Randomized trial of a protable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy
39. A cross-cultural consumer-based decision aid for screening mammography
40. How does physician advice influence patient behavior? Evidence for a priming effect
41. Treating people with information: An analysis and review of approaches to communicating health risk information
42. The role of numeracy in understanding the benefit of screening mammography
43. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial
44. Prevention. How much harm? How much benefit? 4. The ethics of informed consent for preventive screening programs
45. Implementing shared decision-making in routine practice: Barriers and opportunities
46. Physician-patient discussions of controversial cancer screening tests
47. How doctors and patients discuss routine clinical decisions. Informed decision making in the outpatient setting
48. The importance of patient preference in the decision to screen for prostate cancer
49. Measuring the public's health in an era of accountability: Lessons from HEDIS. Health Plan Employer Data and Information Set
50. Patient choice modules for summaries of clinical effectiveness: A proposal
51. Cancer screening decisions
52. What is the right cancer screening rate?